UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pseudaminic Acid on Campylobacter jejuni Flagella Modulates Dendritic Cell IL-10 Expression via Siglec-10 Receptor: A Novel Flagellin-Host Interaction

The Journal of infectious diseases, 2014-11, Vol.210 (9), p.1487-1498

2014

Volltextzugriff (PDF)

The ligand interactions of B cell Siglecs are involved in the prevention of autoimmunity to sialylated self-antigens and in the quality control of signaling-competent B cells

International immunology, 2023-10, Vol.35 (10), p.461-473

Tsubata, Takeshi

2023

Volltextzugriff (PDF)

がん細胞はCD24によりマクロファージの貪食機構から回避する

ファルマシア, 2020, Vol.56(5), pp.442-442

金子, 豊

2020

Volltextzugriff (PDF)

A Guillain-Barré syndrome-associated SIGLEC10 rare variant impairs its recognition of gangliosides

Journal of autoimmunity, 2021-01, Vol.116, p.102571-102571, Article 102571

2021

Volltextzugriff (PDF)

Molecular Mechanism of Tumor Cell Immune Escape Mediated by CD24/Siglec-10

Frontiers in immunology, 2020-07, Vol.11, p.1324-1324

2020

Volltextzugriff (PDF)

Siglec-10 expression is up-regulated in activated human CD4+ T cells

Human immunology, 2020-02, Vol.81 (2-3), p.101-104

2020

Volltextzugriff (PDF)

Checkpoint CD24 function on tumor and immunotherapy

Frontiers in immunology, 2024-02, Vol.15, p.1367959-1367959

2024

Volltextzugriff (PDF)

Targeting macrophages in hematological malignancies: recent advances and future directions

Journal of hematology and oncology, 2022-08, Vol.15 (1), p.1-110, Article 110

2022

Volltextzugriff (PDF)

Targeting CD24/Siglec-10 signal pathway for cancer immunotherapy: recent advances and future directions

Cancer Immunology, Immunotherapy, 2024-01, Vol.73 (2), p.31-31, Article 31

2024

Volltextzugriff (PDF)

CD52 glycan binds the proinflammatory B box of HMGB1 to engage the Siglec-10 receptor and suppress human T cell function

Proceedings of the National Academy of Sciences - PNAS, 2018-07, Vol.115 (30), p.7783-7788

2018

Volltextzugriff (PDF)

Emerging Immune Checkpoint Molecules on Cancer Cells: CD24 and CD200

International journal of molecular sciences, 2023-10, Vol.24 (20), p.15072

2023

Volltextzugriff (PDF)

Delivery of SIRT1 by cancer-associated adipocyte-derived extracellular vesicles regulates immune response and tumorigenesis of ovarian cancer cells

Clinical & translational oncology, 2024-01, Vol.26 (1), p.190-203

2024

Volltextzugriff (PDF)

The inhibitory receptor Siglec‐G controls the severity of chronic lymphocytic leukemia

EMBO reports, 2023-08, Vol.24 (8), p.e56420-n/a

2023

Volltextzugriff (PDF)

Siglec-10 is associated with survival and natural killer cell dysfunction in hepatocellular carcinoma

The Journal of surgical research, 2015-03, Vol.194 (1), p.107-113

2015

Volltextzugriff (PDF)

Elevated CD19+Siglec-10+ B cell levels are correlated with systemic lupus erythematosus disease activity

International immunopharmacology, 2022-01, Vol.102, p.108403-108403, Article 108403

2022

Volltextzugriff (PDF)

IMM47, a humanized monoclonal antibody that targets CD24, exhibits exceptional anti-tumor efficacy by blocking the CD24/Siglec-10 interaction and can be used as monotherapy or in combination with anti-PD1 antibodies for cancer immunotherapy

Antibody therapeutics, 2023-10, Vol.6 (4), p.240-252

2023

Volltextzugriff (PDF)

Malignant ascite-derived extracellular vesicles inhibit T cell activity by upregulating Siglec-10 expression

Cancer management and research, 2019-07, Vol.11, p.7123-7134

2019

Volltextzugriff (PDF)

Phenotypic Characterization by Single-Cell Mass Cytometry of Human Intrahepatic and Peripheral NK Cells in Patients with Hepatocellular Carcinoma

Cells (Basel, Switzerland), 2021-06, Vol.10 (6), p.1495

2021

Volltextzugriff (PDF)

Targeting CD24 in Cancer Immunotherapy

Biomedicines, 2023-11, Vol.11 (12), p.3159

2023

Volltextzugriff (PDF)

Molecular characterization of porcine Siglec-10 and analysis of its expression in blood and tissues

Developmental and comparative immunology, 2015-01, Vol.48 (1), p.116-123

2015

Volltextzugriff (PDF)

Cloning and Characterization of Siglec-10, a Novel Sialic Acid Binding Member of the Ig Superfamily, from Human Dendritic Cells

The Journal of biological chemistry, 2001-07, Vol.276 (30), p.28106-28112

2001

Volltextzugriff (PDF)

Molecular analysis of human Siglec-8 orthologs relevant to mouse eosinophils: identification of mouse orthologs of Siglec-5 (mSiglec-F) and Siglec-10 (mSiglec-G)

Genomics (San Diego, Calif.), 2003-11, Vol.82 (5), p.521-530

2003

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(22)

Sprache

Englisch
(21)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pseudaminic Acid on Campylobacter jejuni Flagella Modulates Dendritic Cell IL-10 Expression via Siglec-10 Receptor: A Novel Flagellin-Host Interaction

The ligand interactions of B cell Siglecs are involved in the prevention of autoimmunity to sialylated self-antigens and in the quality control of signaling-competent B cells

がん細胞はCD24によりマクロファージの貪食機構から回避する

A Guillain-Barré syndrome-associated SIGLEC10 rare variant impairs its recognition of gangliosides

Molecular Mechanism of Tumor Cell Immune Escape Mediated by CD24/Siglec-10

Siglec-10 expression is up-regulated in activated human CD4+ T cells

Checkpoint CD24 function on tumor and immunotherapy

Targeting macrophages in hematological malignancies: recent advances and future directions

Targeting CD24/Siglec-10 signal pathway for cancer immunotherapy: recent advances and future directions

CD52 glycan binds the proinflammatory B box of HMGB1 to engage the Siglec-10 receptor and suppress human T cell function

Emerging Immune Checkpoint Molecules on Cancer Cells: CD24 and CD200

Delivery of SIRT1 by cancer-associated adipocyte-derived extracellular vesicles regulates immune response and tumorigenesis of ovarian cancer cells

The inhibitory receptor Siglec‐G controls the severity of chronic lymphocytic leukemia

Siglec-10 is associated with survival and natural killer cell dysfunction in hepatocellular carcinoma

Elevated CD19+Siglec-10+ B cell levels are correlated with systemic lupus erythematosus disease activity

IMM47, a humanized monoclonal antibody that targets CD24, exhibits exceptional anti-tumor efficacy by blocking the CD24/Siglec-10 interaction and can be used as monotherapy or in combination with anti-PD1 antibodies for cancer immunotherapy

Malignant ascite-derived extracellular vesicles inhibit T cell activity by upregulating Siglec-10 expression

Phenotypic Characterization by Single-Cell Mass Cytometry of Human Intrahepatic and Peripheral NK Cells in Patients with Hepatocellular Carcinoma

Targeting CD24 in Cancer Immunotherapy

Molecular characterization of porcine Siglec-10 and analysis of its expression in blood and tissues

Cloning and Characterization of Siglec-10, a Novel Sialic Acid Binding Member of the Ig Superfamily, from Human Dendritic Cells

Molecular analysis of human Siglec-8 orthologs relevant to mouse eosinophils: identification of mouse orthologs of Siglec-5 (mSiglec-F) and Siglec-10 (mSiglec-G)

Suchergebnisse filtern